Apr 15, 2014 at 18:46 | Source: Moneycontrol.com
Panyam Cements & Mineral Industries has informed that the Board of Directors of the Company at its meeting held on April 15, 2014 have considered and accepted the resignation of Sri S. P. Y. Reddy., Director of the Company with effect from April 01, 2014.
Apr 15, 2014 at 18:45 | Source: Moneycontrol.com
Integrated Thermoplastics has informed that the Board of Directors of the Company at its meeting held on April 15, 2014, approved the resignation tendered by Shri. S. P. Y. Reddy as the Director of the Company w.e.f. April 01, 2014.
Feb 13, 2014 at 12:56 | Source: IBNLive.com
After Telangana Bill was tabled in the Lok Sabha, expelled Congress MP L Rajagopal used pepper spray in the House, leading to chaos. Some MPs also came to blows. There were ugly scenes in the Rajya Sabha too
Jan 03, 2014 at 17:34 | Source: Moneycontrol.com
Pharma companies are likely to post 12 percent Y-o-Y revenue growth. However, excluding Wockhardt (FDA issues) and Fortis Healthcare (divestments), revenue growth is expected to be 19 percent Y-o-Y.
Oct 31, 2013 at 09:11 | Source: Moneycontrol.com
According to Prabhudas Lilladher, sales of Dr Reddys Laboratories are expected to increase by 18.3 percent Q-o-Q (up 16.8 percent Y-o-Y) to Rs 3,366.1 crore.
Oct 31, 2013 at 09:00 | Source: Moneycontrol.com
According to Motilal Oswal, Sales of Dr Reddys Laboratories are expected to increase by 20.5 percent Q-o-Q (up 20.8 percent Y-o-Y) to Rs 3,361.5 crore.
Oct 30, 2013 at 18:39 | Source: Moneycontrol.com
According to a CNBC-TV18 poll, profit after tax is expected to rise 22 percent year-on-year to Rs 498 crore from Rs 407.4 crore and revenues are likely to increase 16 percent Y-o-Y to Rs 3,340 crore in the quarter gone by.
Jul 29, 2013 at 18:17 | Source: Moneycontrol.com
The generic drugs maker's earnings will be boosted by strong growth in the US and Russian generics drugs market and better currency realisations.
Jun 07, 2013 at 15:26 | Source: Moneycontrol.com
RBI governor D Subbrarao on Friday hinted at frequent interventions to step the Indian rupee's fall against a US dollar. Rupee depreciation does not bring competitiveness among exporters, who should concentrate on productivity, he said.
Apr 16, 2013 at 13:30 | Source: Moneycontrol.com
Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY and EBITDA growth of 21.3% YoY for our pharma universe (excluding one-offs).